Table of Contents Author Guidelines Submit a Manuscript
International Journal of Nephrology
Volume 2012 (2012), Article ID 154397, 7 pages
http://dx.doi.org/10.1155/2012/154397
Clinical Study

Transcription of the Tumor Suppressor Genes p53 and RB in Lymphocytes from Patients with Chronic Kidney Disease: Evidence of Molecular Senescence?

1Department of Medical Biopathology and Clinical Microbiology, Aeginition Hospital, Medical School, University of Athens, 115 28 Athens, Greece
2Department of Nephrology, General Hospital of Athens, “G. Gennimatas”, 115 27 Athens, Greece
3Department of Nursing, Sparta General Hospital Building Complex, Faculty of Human Movement and Quality of Life Sciences, University of Peloponnese, 23 100 Sparta, Greece
4Department of Statistics and Insurance Science, University of Piraeus, 185 34 Piraeus, Greece

Received 7 June 2012; Revised 18 August 2012; Accepted 21 August 2012

Academic Editor: Alejandro Martín-Malo

Copyright © 2012 Vasileios Kordinas et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. I. C. Macdougall, “Could anti-inflammatory cytokine therapy improve poor treatment outcomes in dialysis patients?” Nephrology Dialysis Transplantation, vol. 19, supplement 5, pp. v73–v78, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. J. H. Song and H. D. Humes, “Renal cell therapy and beyond,” Seminars in Dialysis, vol. 22, no. 6, pp. 603–609, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. P. Stenvinkel, M. Ketteler, R. J. Johnson et al., “IL-10, IL-6, and TNF-α: central factors in the altered cytokine network of uremia—the good, the bad, and the ugly,” Kidney International, vol. 67, no. 4, pp. 1216–1233, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. L. Bai and W. G. Zhu, “p53 : structure, function and therapeutic applications,” Journal of Cancer Molecules, vol. 2, no. 4, pp. 141–153, 2006. View at Google Scholar
  5. L. Khidr and P. L. Chen, “RB, the conductor that orchestrates life, death and differentiation,” Oncogene, vol. 25, no. 38, pp. 5210–5219, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. R. A. Weinberg, “The retinoblastoma protein and cell cycle control,” Cell, vol. 81, no. 3, pp. 323–330, 1995. View at Google Scholar · View at Scopus
  7. A. Cukusić, N. Skrobot Vidacek, M. Sopta, and I. Rubelj, “Telomerase regulation at the crossroads of cell fate,” Cytogenetic and Genome Research, vol. 122, no. 3-4, pp. 263–272, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. G. Tsirpanlis, S. Chatzipanagiotou, F. Boufidou et al., “Telomerase activity is decreased in peripheral blood mononuclear cells of hemodialysis patients,” American Journal of Nephrology, vol. 26, no. 1, pp. 91–96, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. G. Tsirpanlis, S. Chatzipanagiotou, F. Boufidou et al., “Serum oxidized low-density lipoprotein is inversely correlated to telomerase activity in peripheral blood mononuclear cells of haemodialysis patients,” Nephrology, vol. 11, no. 6, pp. 506–509, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. H. S. Warren, C. Fitting, E. Hoff et al., “Resilience to bacterial infection: difference between species could Be due to proteins in serum,” Journal of Infectious Diseases, vol. 201, no. 2, pp. 223–232, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. M. B. Pepys and G. M. Hirschfield, “C-reactive protein: a critical update,” Journal of Clinical Investigation, vol. 111, no. 12, pp. 1805–1812, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. B. McMahon and C. Godson, “Lipoxins: endogenous regulators of inflammation,” American Journal of Physiology—Renal Physiology, vol. 286, no. 2, pp. F189–F201, 2004. View at Google Scholar · View at Scopus
  13. A. E. Baird, “Blood genomics in human stroke,” Stroke, vol. 38, supplement 2, pp. 694–698, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. R. R. Reddel, “Genes involved in the control of cellular proliferative potential,” Annals of the New York Academy of Sciences, vol. 854, pp. 8–19, 1998. View at Publisher · View at Google Scholar · View at Scopus
  15. D. Donjerkovic and D. W. Scott, “Regulation of the G1 phase of the mammalian cell cycle,” Cell Research, vol. 10, no. 1, pp. 1–16, 2000. View at Google Scholar · View at Scopus
  16. T. Miyamoto, J. J. Carrero, and P. Stenvinkel, “Inflammation as a risk factor and target for therapy in chronic kidney disease,” Current Opinion in Nephrology and Hypertension, vol. 20, no. 6, pp. 662–668, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Jimenez, J. Carracedo, R. Santamaría et al., “Replicative senescence in patients with chronic kidney failure,” Kidney International, vol. 68, supplement 99, pp. S-11–S-15, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. G. Guarnieri, G. Grassi, R. Barazzoni, M. Zanetti, and G. Biolo, “The impact of inflammation on metabolic regulation in chronic kidney disease: a review,” Journal of Renal Nutrition, vol. 15, no. 1, pp. 121–124, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. D. Liu and Y. Xu, “P53, oxidative stress, and aging,” Antioxidants and Redox Signaling, vol. 15, no. 6, pp. 1669–1678, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. D. V. Barreto, F. C. Barreto, S. Liabeuf et al., “Plasma interleukin-6 is independently associated with mortality in both hemodialysis and pre-dialysis patients with chronic kidney disease,” Kidney International, vol. 77, no. 6, pp. 550–556, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. D. M. Silverstein, “Inflammation in chronic kidney disease: role in the progression of renal and cardiovascular disease,” Pediatric Nephrology, vol. 24, no. 8, pp. 1445–1452, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. W. W. Cheung, K. H. Paik, and R. H. Mak, “Inflammation and cachexia in chronic kidney disease,” Pediatric Nephrology, vol. 25, no. 4, pp. 711–724, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. P. Stenvinkel, “Inflammation in end-stage renal disease: the hidden enemy,” Nephrology, vol. 11, no. 1, pp. 36–41, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. G. Trinchieri, M. Kubin, G. Bellone, and M. A. Cassatella, “Cytokine cross-talk between phagocytic cells and lymphocytes: Relevance for differentiation/activation of phagocytic cells and regulation of adaptive immunity,” Journal of Cellular Biochemistry, vol. 53, no. 4, pp. 301–308, 1993. View at Google Scholar · View at Scopus
  25. J. Banchereau, F. Brière, Y. J. Liu, and F. Rousset, “Molecular control of B lymphocyte growth and differentiation,” Stem Cells, vol. 12, no. 3, pp. 278–288, 1994. View at Google Scholar · View at Scopus
  26. J. J. Carrero, P. Stenvinkel, B. Fellström et al., “Telomere attrition is associated with inflammation, low fetuin-A levels and high mortality in prevalent haemodialysis patients,” Journal of Internal Medicine, vol. 263, no. 3, pp. 302–312, 2008. View at Publisher · View at Google Scholar · View at Scopus